[Giant chondrosarcoma: a case report].
Chondrosarcoma is a slow-growing malignant tumor, with a mainly local infiltration, usually arising from skeletal cartilaginous cells. However, a few such neoplasms also arise from extraskeletal mesenchymal cells. Metastasis are usually seen with undifferentiated tumors (grade III), mainly within the lungs. The best treatment associates total surgical resection with chemotherapy. Radiotherapy is of poor use. Isolated pulmonary metastasis can be profitably withdrawn. Prognosis is about of 75% of survival after 10 years, in case of well-differentiated tumors (grade I). The prognosis is far worse for undifferentiated tumors (grade III), turning around 10% of survival after 10 years.
Bouharras
M
M
Service de chirurgie, Clinique et Maternité St-Joseph, Arlon.
Deldime
P
P
Storck
M
M
D000008:Abdominal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D002813:Chondrosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D003131:Combined Modality Therapy; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography
D015251:Epirubicin; D016190:Carboplatin
Chondrosarcome géant: a case report.